First Trust Nasdaq Pharmaceuticals ETF Rating $26.98 +0.24 (+0.90%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends First Trust Nasdaq Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FTXH Aggregate RatingModerate Buy 2.60Holdings in FTXH have an aggregate rating of Moderate Buy based on 741 analyst ratings issued in the past year covering 50 companies (100.0% of the portfolio).FTXH Aggregate Price Target$26.98High Prediction$26.98Average Prediction$26.98Low Prediction$26.98Holdings in FTXH have an aggregate price target of $26.98 and a range of $26.98 to $26.98 covering 50 companies (100.0% of the portfolio).FTXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy30 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Nasdaq Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 FTXH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.93%BMYBristol-Myers Squibb$57.33+1.8%4.7872 of 5 stars2.25$55.64 -2.9%20High Trading Volume6.83%JNJJohnson & Johnson$144.47+0.6%4.8952 of 5 stars2.50$174.73 20.9%14High Trading Volume6.80%ABBVAbbVie$175.58+2.4%4.9342 of 5 stars2.88$205.70 17.2%24Analyst ForecastInsider TradeHigh Trading Volume6.71%PFEPfizer$26.36+2.3%4.9837 of 5 stars2.47$32.14 21.9%17Analyst ForecastOptions VolumeAnalyst RevisionHigh Trading Volume6.62%MRKMerck & Co., Inc.$98.05-1.5%4.9889 of 5 stars2.71$127.13 29.7%21Analyst DowngradeHigh Trading Volume4.48%GILDGilead Sciences$92.57+1.6%4.4929 of 5 stars2.67$96.43 4.2%27Insider TradePositive NewsHigh Trading Volume4.13%CAHCardinal Health$118.28+1.1%4.7239 of 5 stars2.62$127.50 7.8%13Analyst ForecastHigh Trading Volume4.04%VTRSViatris$12.52+3.2%2.056 of 5 stars2.00$13.67 9.2%3News CoverageHigh Trading Volume3.77%UTHRUnited Therapeutics$359.58-0.2%4.7129 of 5 stars2.73$370.86 3.1%15Analyst DowngradeInsider TradePositive NewsHigh Trading Volume3.61%ZTSZoetis$164.84+0.8%4.6044 of 5 stars3.09$215.22 30.6%11High Trading Volume3.41%JAZZJazz Pharmaceuticals$122.97+0.1%4.8539 of 5 stars2.87$177.00 43.9%15High Trading Volume3.26%LLYEli Lilly and Company$767.76+1.3%4.9956 of 5 stars2.81$1,002.22 30.5%21Gap UpHigh Trading Volume3.11%AMGNAmgen$263.38+0.8%4.4715 of 5 stars2.40$319.67 21.4%25Analyst DowngradeGap UpHigh Trading Volume2.95%BIIBBiogen$146.47-0.6%4.6302 of 5 stars2.45$242.68 65.7%29Analyst DowngradeHigh Trading Volume2.47%OGNOrganon & Co.$14.58+1.0%4.8014 of 5 stars2.50$21.33 46.3%4High Trading Volume2.46%REGNRegeneron Pharmaceuticals$701.85-0.9%4.6587 of 5 stars2.70$1,052.90 50.0%23Analyst ForecastHigh Trading Volume2.40%CRLCharles River Laboratories International$185.77+2.0%4.5242 of 5 stars1.93$214.00 15.2%151.83%MEDPMedpace$337.28+0.6%4.687 of 5 stars2.45$380.56 12.8%11High Trading Volume1.58%ELANElanco Animal Health$11.63-1.6%3.7792 of 5 stars2.25$16.71 43.7%81.43%NBIXNeurocrine Biosciences$135.42+0.3%4.8286 of 5 stars2.83$166.00 22.6%23Analyst ForecastInsider TradePositive NewsHigh Trading Volume1.17%ALKSAlkermes$29.71-0.9%4.6608 of 5 stars2.58$35.42 19.2%12Positive NewsHigh Trading Volume1.15%EXELExelixis$33.29-1.2%4.5106 of 5 stars2.50$32.44 -2.6%18Analyst DowngradeAnalyst RevisionHigh Trading Volume1.06%HALOHalozyme Therapeutics$46.96-0.8%4.9948 of 5 stars2.60$61.11 30.1%10Analyst ForecastPositive NewsHigh Trading Volume1.03%PRGOPerrigo$25.75+0.1%4.9867 of 5 stars2.75$37.00 43.7%4Positive News1.01%PBHPrestige Consumer Healthcare$78.72+0.1%3.7982 of 5 stars2.50$85.25 8.3%4Analyst UpgradePositive NewsHigh Trading Volume0.89%CORTCorcept Therapeutics$51.40+0.5%4.9121 of 5 stars3.00$65.25 26.9%5Analyst RevisionHigh Trading Volume0.75%TGTXTG Therapeutics$32.20+4.0%4.3127 of 5 stars2.83$40.67 26.3%6Positive News0.72%PTGXProtagonist Therapeutics$41.49+4.9%3.5882 of 5 stars3.00$53.78 29.6%9News CoveragePositive NewsHigh Trading Volume0.66%ACLXArcellx$75.54+0.4%3.1377 of 5 stars3.13$105.93 40.2%15Positive NewsHigh Trading Volume0.63%ALNYAlnylam Pharmaceuticals$245.44+2.8%4.4132 of 5 stars2.71$298.09 21.5%24Analyst Upgrade0.62%TWSTTwist Bioscience$47.94+9.9%2.5561 of 5 stars2.70$51.90 8.3%10High Trading Volume0.60%ITCIIntra-Cellular Therapies$83.45-0.8%4.0477 of 5 stars2.85$97.23 16.5%130.60%INCYIncyte$68.84+2.7%4.7054 of 5 stars2.35$76.29 10.8%20Analyst ForecastHigh Trading Volume0.59%ADMAADMA Biologics$17.40-2.8%3.7751 of 5 stars3.25$21.25 22.1%40.58%VCELVericel$56.50+2.8%1.4381 of 5 stars3.14$61.14 8.2%7Analyst Forecast0.53%EXASExact Sciences$59.40+5.9%4.4914 of 5 stars2.94$72.94 22.8%180.53%ACADACADIA Pharmaceuticals$16.87+0.8%3.8468 of 5 stars2.63$25.60 51.7%16High Trading Volume0.52%BPMCBlueprint Medicines$90.14+1.4%2.5701 of 5 stars2.71$122.11 35.5%21Insider Trade0.52%INSMInsmed$70.44+1.5%2.9718 of 5 stars3.00$83.67 18.8%16Insider TradeHigh Trading Volume0.52%AMRXAmneal Pharmaceuticals$7.78+0.4%2.8853 of 5 stars2.80$10.00 28.5%5Analyst DowngradeNews Coverage0.52%ROIVRoivant Sciences$11.57+0.6%3.0007 of 5 stars2.88$17.93 55.0%8Insider TradeHigh Trading Volume0.49%SRPTSarepta Therapeutics$118.97-0.4%4.8145 of 5 stars2.91$178.71 50.2%22Analyst Forecast0.49%KRYSKrystal Biotech$164.83+2.5%4.5187 of 5 stars3.00$206.67 25.4%8Analyst ForecastHigh Trading Volume0.49%VRTXVertex Pharmaceuticals$397.27+0.2%4.7526 of 5 stars2.52$499.77 25.8%31Analyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume0.48%KYMRKymera Therapeutics$40.66+3.9%2.27 of 5 stars2.83$53.88 32.5%180.44%RNAAvidity Biosciences$31.82+2.5%2.1828 of 5 stars3.00$64.36 102.3%11Analyst ForecastInsider TradeAnalyst RevisionNews CoverageHigh Trading Volume0.43%BMRNBioMarin Pharmaceutical$65.66+1.0%4.9845 of 5 stars2.74$94.20 43.5%23Positive NewsHigh Trading Volume0.41%IONSIonis Pharmaceuticals$35.63+0.1%4.4164 of 5 stars2.68$60.65 70.2%19Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageHigh Trading Volume0.41%VKTXViking Therapeutics$42.25+1.8%4.2931 of 5 stars3.15$106.75 152.7%13Analyst ForecastGap Up0.30%MYGNMyriad Genetics$13.36+1.4%4.4478 of 5 stars2.00$24.27 81.7%12High Trading Volume This page (NASDAQ:FTXH) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
